Erasca

IDEAYA Biosciences

This precision medicine company develops targeted oncology therapeutics for patients with solid tumours and molecularly defined cancers.

Scorpion

This company develops small molecule precision oncology therapies for patients with various cancers.

Enedra Therapeutics Ltd

This company develops precision medicines and biomarkers to treat advanced, genetically heterogeneous cancers for patients with drug-resistant tumours.

Black Diamond Therapeutics

This clinical-stage company develops precision oncology medicines and small molecule therapies for patients with genetically defined cancers.

Fore Biotherapeutics

This precision oncology company develops targeted therapies for patients with unaddressed cancer mutations, including a specific BRAF inhibitor for advanced solid tumours.

Mariana Oncology

This company develops precision radioligand therapies to treat cancer patients with solid tumours.

ARase Therapeutics

This company develops small molecule drugs targeting ADP-ribose hydrolases for patients with various forms of cancer.

Khora

This clinical-stage precision oncology company develops targeted small-molecule therapeutics, including CDK and FGFR inhibitors, for patients with diverse cancer types.